Effectiveness, Tolerability, Safety of Rasagiline in Early Parkinson's Disease Patients Without Levodopa

Study Title
Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa
Teva Identifier
TVP-1012/232
ClinicalTrials.gov Identifier
NCT00203060
Study Status
Completed
Trial Condition(s)
Parkinson's Disease
Interventions
Drug: Rasagiline Mesylate | Drug: placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
35 Years and older
Trial Duration
07/01/1997 - 07/01/2000
Phase
Phase 3

Study Type

Interventional